Drug Channels Institute (DCI) is a leading provider of specialized management education and computer-based training for and about the pharmaceutical industry. >

E-LEARNING MODULES

DCI delivers educational solutions for clients that enhance the business acumen of employees, from senior executives to field reps to internal operations. State-of-the-art instructional design, coupled with extensive industry knowledge, allows DCI to build rigorous programs with accurate, fact-based content reflecting the latest developments. Even better, we deliver the material in an engaging, accessible manner using turn-key technology solutions. View samples of our modules

View Sample

Industry Reports

2013-14 Economic Report on Retail, Mail, and Specialty Pharmacies

This completely updated, revised, and expanded of the $287 billion U.S. pharmacy industry thoroughly dissects its interactions with the U.S. healthcare system. more >

2014-15 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

The $300 billion U.S. drug wholesaling industry is undergoing dramatic change. Understanding the implications of the industry’s evolution has never been more crucial. more >

From The Drug Channels Blog

News Roundup, October 2014: Walgreens, Cardinal Health, Generics, Marley Drugs, and Roger Daltrey

Eeek! Time for my Halloween-themed roundup of Drug Channels news stories. In this issue:Icky: Walgreen’s ex-CFO alleges defamationSpooky: Generic inflation is changing benefit designIt’s alive! An independent pharmacy thrives with a more >

Sovaldi: The Legendary Blockbuster

Yesterday, Gilead Sciences reported another blockbuster quarter for Sovaldi sales. (Read the press release.) But just how good was Sovaldi’s launch?Mark Schoenebaum of ISI Group compared hepatis C treatment Sovaldi’s more >